LadRx Corp. (LADX)

0.11 +0.08 (+266.67%) USD  |  OTCM  |  Feb 24, 16:00
More

LadRx EPS Diluted from Accounting Change (Quarterly)

EPS Diluted from Accounting Change (Quarterly) Chart

View EPS Diluted from Accounting Change (Quarterly) for LADX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted from Accounting Change (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted from Accounting Change (Quarterly) Range, Past 5 Years

View EPS Diluted from Accounting Change (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Accounting Change (Quarterly) Benchmarks

View EPS Diluted from Accounting Change (Quarterly) Benchmarks
Start Trial
Agenus, Inc. --
Curis, Inc. --
Plus Therapeutics, Inc. --
Windtree Therapeutics, Inc. --
Enzon Pharmaceuticals, Inc. --